Adjuvant cytotoxic chemotherapy in association with radical surgery or radical radiation treatment in presumably localized prostatic cancer.
The potential benefit of adjuvant cytotoxic chemotherapy after radical surgical or radiation treatment of prostate cancer is discussed in the light of available reported studies. It is concluded that the effect of such treatment must still be regarded as uncertain and that further trials are needed.
Chatelain
C
C
Department of Urology, Ch Pitié-Salpétrière, Paris, France.
D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery